H.C. Wainwright reiterates Buy on Pyxis Oncology stock, $7 target
Corroborated by 1 source from 1 publisher
globalbusiness2h ago
TL;DR
H.C. Wainwright reiterates Prothena stock rating on Parkinson’s data H.C. Wainwright reiterates Buy on Pyxis Oncology stock, $7 target.